Clinical and prognostic features of acute alcoholic pancreatitis

Jiang Xin; Xu Huan; Yan YongFeng; Zhong Rui; Luo XuJuan; Shi XiaoMin; Wang Min; Peng Yan; Tang XiaoWei

doi:10.3969/j.issn.1001-5256.2019.11.027

Volume 35 Issue 11

Nov. 2019

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2019 > 35(11): 2528-2532

PDF( 2062 KB)

Clinical and prognostic features of acute alcoholic pancreatitis

DOI: 10.3969/j.issn.1001-5256.2019.11.027

Department of Gastroenterology,The Affiliated Hospital of Southwest Medical University

Research funding:

Received Date: 2019-07-15
Published Date: 2019-11-20

Abstract

Abstract

Objective To investigate the clinical and prognostic features of acute alcoholic pancreatitis. Methods A total of 467 patients with incipient acute pancreatitis( AP) who were admitted to The Affiliated Hospital of Southwest Medical University from July 2013 to July2018 were enrolled as subjects,and among these patients,182 with alcoholic AP were enrolled as alcoholic group and 285 with biliary AP were enrolled as biliary group. The two groups were compared in terms of the clinical features such as age,sex,laboratory markers,disease grade,complications,and prognostic indices. The independent samples t-test was used for comparison of normally distributed continuous data between two groups,and the Mann-Whitney U test was used for comparison of non-normally distributed continuous data between two groups. The chi-square test or the Fisher's exact test was used for comparison of categorical data between two groups,and the Mann-Whitney U test was used for comparison of ranked data between two groups. Results Compared with the biliary group,the alcoholic group had significantly higher constituent ratio of male patients( 74. 2% vs 48. 1%,χ2= 31. 124,P < 0. 001) and proportion of patients with fatty liver disease( 34. 1% vs 24. 9%,χ2= 4. 569,P = 0. 033). The biliary group had a significantly higher proportion of patients with hypertension than the alcoholic group( 23. 5% vs 15. 4%,χ2= 4. 524,P = 0. 033). Compared with the biliary group,the alcoholic group had significantly higher levels of creatinine and triglyceride( Z =-4. 828,t = 7. 916,both P < 0. 001),proportion of patients with severe AP( 34. 6% vs 15. 1%,Z =-4. 787,P < 0. 001),and CTSI score( 4. 6 ± 1. 7 vs 4. 2 ± 1. 5,t = 2. 672,P = 0. 008). Compared with the biliary group,the alcoholic group had significantly higher probabilities of acute peripancreatic fluid accumulation( 61. 0% vs 49. 8%,χ2=5. 045,P < 0. 05),pancreatic pseudocyst( 11. 5% vs 4. 2%,χ2= 8. 881,P < 0. 05),infectious pancreatic necrosis( 37. 9% vs 19. 6%,χ2= 18. 899,P < 0. 05),and renal failure( 19. 2% vs 8. 4%,χ2= 11. 758,P < 0. 05). Compared with the biliary group,the alcoholic group had significantly longer time to intestinal function recovery,time to relief of abdominal pain,and length of hospital stay( t =-4. 078,-3. 357,and-2. 527,all P < 0. 05). There was a significant difference in mortality rate between the alcoholic group and the biliary group( 7. 1% vs 3. 2%,χ2= 3. 929,P = 0. 047). Conclusion Compared with the biliary group,the alcoholic group has a higher risk of complications,worse clinical manifestations,and a higher mortality rate. Therefore,alcohol abstinence education should be performed for this population,especially men,in order to reduce adverse outcomes.
- pancreatitis,alcoholic,
- cholelithiasis,
- signs and symptoms,
- prognosis

FullText(HTML)

References(34)

References

[1] WANG CY,LI F,ZHAO YP,et al. Treatment of acute pancreatitis(2014)[J]. J Clin Hepatol,2015,31(1):17-20.(in Chinese)王春友，李非，赵玉沛，等．急性胰腺炎诊治指南(2014)[J]．临床肝胆病杂志，2015,31(1):17-20.

[2] CROCKETT SD,WANI S,GARDNER TB,et al. American Gastroenterological Association Institute Guideline on initial management of acute pancreatitis[J]. Gastroenterology,2018,154(4):1096-1101.

[3] GULLO L,MIGLIORI M,OLAH A,et al. Acute pancreatitis in five European countries:Etiology and mortality[J]. Pancreas,2002,24(3):223-227.

[4] HUANG LB,TANG CW,XIE YM,et al. Risk factors of 3073cases of acute pancreatitis in Chengdu[J]. J Sichuan Univ:Med Sci Ed,2005,36(1):138-139.(in Chinese)黄丽彬，唐承薇，谢咏梅，等．成都地区3073例急性胰腺炎致病危险因素分析[J]．四川大学学报:医学版，2005,36(1):138-139.

[5] FENG ZD,LIU ZJ. Clinical analysis of early and delayed laparoscopic cholecystectomy for mild acute biliary pancreatitis[J]. Chin J Med Offic,2018,46(2):213-215.(in Chinese)冯章东，刘佐军．早期与延期腹腔镜胆囊切除术治疗轻型急性胆源性胰腺炎临床疗效分析[J]．临床军医杂志，2018,46(2):213-215.

[6] WU HH. Clinical characteristics and prognosis of acute biliary pancreatitis and acute alcoholic pancreatitis[J]. J Qiqihar Med Coll,2015,36(12):1794-1795.(in Chinese)吴航海．急性胆源性胰腺炎与急性酒精性胰腺炎的临床特点及预后分析[J]．齐齐哈尔医学院学报，2015,36(12):1794-1795.

[7] YU XE,DENG YH,HUANG PN,et al. Clinical study on alcoholic effect in the severity of acute pancreatitis[J]. Chin J Gastroenterol Hepatol,2015,24(7):875-878.(in Chinese)余贤恩，邓有辉，黄培宁，等．酒精在急性胰腺炎重症化中作用的临床研究[J]．胃肠病学和肝病学杂志，2015,24(7):875-878.

[8] LI Q,WU PF,XU ZK,et al. Clinical and prognostic analysis of85 cases of alcoholic acute pancreatitis[J]. Jiangsu Med J,2013,39(24):3025-3026.(in Chinese)李强，吴鹏飞，徐泽宽，等．85例酒精性急性胰腺炎的临床与预后分析[J]．江苏医药，2013,39(24):3025-3026.

[9] ZHAO B. Clinical characteristics and prognosis of acute biliary pancreatitis and acute alcoholic pancreatitis[J]. Mod Diagn Treat,2013,24(13):3058-3059.(in Chinese)赵波．急性胆源性胰腺炎与急性酒精性胰腺炎的临床特点及预后分析[J]．现代诊断与治疗，2013,24(13):3058-3059.

[10] BANKS PA,BOLLEN TL,DERVENIS C,et al. Classification of acute pancreatitis-2012:Revision of the Atlanta classification and definitions by international consensus[J]. Gut,2013,62(1):102-111.

[11] TENNER S,BAILLIE J,DEWITT J,et al. American College of Gastroenterology Guidelines:Management of acute pancreatitis[J]. Am J Gastroenterol,2013,108(9):1400-1415,1416.

[12] ZHANG N,ZHANG HY,GUO XH,et al. Changes of etiology in acute pancreatitis in recent 10 years in China:Meta-analysis[J/CD]. Chin J Digest Med Imageol:Electronic Edition,2016,6(2):71-75.(in Chinese)张娜，张海燕，郭晓红，等．中国近十年急性胰腺炎病因变化特点的Meta分析[J/CD]．中华消化病与影像杂志:电子版，2016,6(2):71-75.

[13] CHEN YT. Investigation of etiology and clinical characteristics of acute pancreatitis in four hospitals in Xi'an[D]. Yinchuan:Ningxia Medical University,2016.(in Chinese)陈依婷．西安市四家医院的急性胰腺炎病因调查及临床特点分析[D]．银川:宁夏医科大学，2016.

[14] RUAN JG,SUN JL,ZANG Y. Etiology and clinical characteristics of acute pancreatitis[J]. J Ningxia Med Univ,2016,38(7):791-794.(in Chinese)阮继刚，孙金玲，臧媛．急性胰腺炎的病因及临床特征分析[J]．宁夏医科大学学报，2016,38(7):791-794.

[15] LI ZF,ZHAO Q,WANG B. Analysis of the etiology of acute pancreatitis in Southwest Shandong Province in the past 20years[J]. Chin J Pancreatol,2018,18(6):399-401.(in Chinese)李振方，赵琦，王兵．山东鲁西南地区近20年急性胰腺炎患者病因变化分析[J]．中华胰腺病杂志，2018,18(6):399-401.

[16] KONG LX,ZHANG JW. Severity and local complications of acute pancreatitis based on etiology[J]. Lab Med Clin,2016,13(9):1209-1210,1213.(in Chinese)孔琳熙，张俊文．急性胰腺炎病因与局部并发症及严重程度的相关性分析[J]．检验医学与临床，2016,13(9):1209-1210,1213.

[17] STERNBY H,BOLADO F,CANAVAL-ZULETA HJ,et al. Determinants of severity in acute pancreatitis:A nation-wide multicenter prospective cohort study[J]. Ann Surg,2019,270(2):348-355.

[18] NESVADERANI M,ESLICK GD,VAGG D,et al. Epidemiology,aetiology and outcomes of acute pancreatitis:A retrospective cohort study[J]. Int J Surg,2015,23(Pt A):68-74.

[19] GAPP J,HALL AG,WALTERS RW,et al. Trends and outcomes of hospitalizations related to acute pancreatitis:Epidemiology from 2001 to 2014 in the United States[J]. Pancreas,2019,48(4):548-554.

[20] SAMARASEKERA E,MAHAMMED S,CARLISLE S,et al.Pancreatitis:Summary of NICE guidance[J]. BMJ,2018,362:k3443.

[21] YADAV D,PAPACHRISTOU GI,WHITCOMB DC. Alcoho-associated pancreatitis[J]. Gastroenterol Clin North Am,2007,36(2):219-238.

[22] SATOH K,SHIMOSEGAWA T,MASAMUNE A,et al. Nationwide epidemicological survey of acute pancreatitis in Japan[J]. Pancreas,2011,40(4):503-507.

[23] KRISTIANSEN L,GRNBAEK M,BECKER U,et al. Risk of pancreatitis according to alcohol drinking habits:A population-based cohort study[J]. Am J Epidemiol,2008,168(8):932-937.

[24] ZHU Y,PAN X,ZENG H,et al. A study on the etiology,severity,and mortality of 3260 patients with acute pancreatitis according to the revised atlanta classification in Jiangxi,China over an 8-year period[J]. Pancreas,2017,46(4):504-509.

[25] KIM KO,KIM TN. Acute pancreatic pseudocyst:Incidence,risk factors,and clinical outcomes[J]. Pancreas,2012,41(4):577-581.

[26] FAN LY,JIANG YG,KONG XJ,et al. Risk factors analysis for the formation of pancreatic pseudocysts in acute pancreatitis[J]. Chin J Pancreatol,2018,18(1):20-24.(in Chinese)范丽玉，姜英俊，孔心涓，等．急性胰腺炎并发胰腺假性囊肿形成的危险因素分析[J]．中华胰腺病杂志，2018,18(1):20-24.

[27] CUI ML,KIM KH,KIM HG,et al. Incidence,risk factors and clinical course of pancreatic fluid collections in acute pancreatitis[J]. Dig Dis Sci,2014,59(5):1055-1056.

[28] POORNACHANDRA KS,BHASIN DK,NAGI B,et al. Clinical,biochemical,and radiologic parameters at admission predicting formation of a pseudocyst in acute pancreatitis[J]. J Clin Gastroenterol,2011,45(2):159-163.

[29] YU XE. Analysis of causes and prognosis of 113 patients with severe acute pancreatitis[J]. Chin J Primary Med Pharm,2012,19(4):526-528.(in Chinese)余贤恩．重症急性胰腺炎113例病因及预后分析[J]．中国基层医药，2012,19(4):526-528.

[30] RAZVODOVSKY YE. Alcohol consumption and pancreatitis mortality in Russian[J]. JOP,2014,15(4):365-370.

[31] XU C,QIAO Z,LU Y,et al. Influence of fatty liver on the severity and clinical outcome in acute pancreatitis[J]. PLo S One,2015,10(11):e0142278.

[32] CAI ZZ,LI ZX. Research progress in the pathogenesis of chronic alcoholic pancreatitis[J]. Foreign Medicine(Digestive Diseases),2005,25(6):391-394.(in Chinese)蔡振寨，李兆申．酒精性慢性胰腺炎发病机制研究进展[J]．国外医学(消化系疾病分册)，2005,25(6):391-394.

[33] ZHOU XC,TANG CW,LIU CL. Moderate diet protein intake slows down progression of alcoholic pancreatic acinar cell retrogression[J]. Pancreatology,2006,6(2):69-73.(in Chinese)周旭春，唐承薇，刘纯伦．蛋白质摄入量在酒精性胰腺损伤中的作用[J]．胰腺病学，2006,6(2):69-73.

[34] ZHAO QL,HUANG CY,LI XM. Study on the mechanism of alcohol induced pancreatitis[J]. Chin J Pancreatol,2007,7(1):49-51.(in Chinese)赵秋玲，黄承钰，李晓明．酒精致胰腺炎的机制研究[J]．胰腺病学，2007,7(1):49-51.

Relative Articles

[1]	Aiping TIAN, Yongfeng YANG. Diagnosis of nonalcoholic fatty liver disease: The importance of pathology[J]. Journal of Clinical Hepatology, 2023, 39(3): 491-497. doi: 10.3969/j.issn.1001-5256.2023.03.002
[2]	Liang XU, Ping LI, Lin CHEN, Yuqiang FU. Natural history and non-invasive diagnosis and clinical management of chronic HBV infection overlapping with nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2021, 37(7): 1501-1507. doi: 10.3969/j.issn.1001-5256.2021.07.003
[3]	Aiping WANG, Chunyang WEN. Thoughts on recommendations for immune-tolerant phase of chronic hepatitisB virus infection in Guidelines for the management of hepatitis B (version 3.3) released by the Japan Society of Hepatology[J]. Journal of Clinical Hepatology, 2021, 37(7): 1528-1528. doi: 10.3969/j.issn.1001-5256.2021.07.009
[4]	Li XIAO, Jianchun XIAN. Patients in the immune-tolerant phase of chronic hepatitis B can receive antiviral therapy conditionally[J]. Journal of Clinical Hepatology, 2021, 37(4): 781-782. doi: 10.3969/j.issn.1001-5256.2021.04.010
[5]	Jun JIANG, Fuzhong WU, Deyang WANG. Antiviral therapy for chronic hepatitis B in the indeterminate phase is urgent[J]. Journal of Clinical Hepatology, 2021, 37(11): 2545-2545. doi: 10.3969/j.issn.1001-5256.2021.11.010
[6]	Ling QING, Weiqiang HUANG, Xiaohe LI, Feng CHEN, Yingxia LIU. Efficacy of antiviral therapy for chronic hepatitis B with nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2021, 37(9): 2075-2080. doi: 10.3969/j.issn.1001-5256.2021.09.015
[7]	Yang DING, Xiaoguang DOU. How far are we from the "Treat all" era of antiviral therapy for chronic hepatitis B[J]. Journal of Clinical Hepatology, 2021, 37(11): 2546-2547. doi: 10.3969/j.issn.1001-5256.2021.11.011
[8]	Lina JIANG, Wei Li, Jingmin ZHAO. Current status and perspectives of the clinical and basic research on concomitant chronic hepatitis B virus infection and nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2021, 37(7): 1489-1494. doi: 10.3969/j.issn.1001-5256.2021.07.001
[9]	Yanhua TANG, Xingyu LU, Jian SUN. Chronic hepatitis B virus infection with nonalcoholic fatty liver disease: Problems faced by antiviral therapy[J]. Journal of Clinical Hepatology, 2021, 37(7): 1508-1514. doi: 10.3969/j.issn.1001-5256.2021.07.004
[10]	Li WenMi, Wang Nan, Bian Qian, Huang Qian, Li JingTao, Wei HaiLiang, Yan ShuGuang. Role of liver X receptor in nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2020, 36(10): 2349-2352. doi: 10.3969/j.issn.1001-5256.2020.10.041
[11]	Yao ChengZi, Feng Gong, Yu WenSi, Du Huan, Mi Man. Risk factors for the development and progression of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2020, 36(2): 433-436. doi: 10.3969/j.issn.1001-5256.2020.02.044
[12]	Chu PeiLing, Wang Qi, Guo XiaoQing, Liu JinChun. Association between chemokines and nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2019, 35(7): 1626-1628. doi: 10.3969/j.issn.1001-5256.2019.07.044
[13]	Lu BingJie, Chen Xi, Sun MingYu. Application of lipid-regulating drugs in prevention and treatment of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2017, 33(12): 2444-2448. doi: 10.3969/j.issn.1001-5256.2017.12.043
[14]	Xie Xiao, Lu LunGen. Potential therapeies for nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2017, 33(12): 2439-2443. doi: 10.3969/j.issn.1001-5256.2017.12.042
[15]	Feng Gong, Niu ChunYan. Advances in the treatment of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2017, 33(12): 2433-2438. doi: 10.3969/j.issn.1001-5256.2017.12.041
[16]	Guo YinYan, Li Peng. A study on the role of serum Retinol Binding Protein 4 in nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2012, 28(4): 279-280+301.
[17]	Qiu RongYuan, He ShengSong, Chen Feng, Pang Ran. Construction of eukaryotic expression vector of P21 mutation type by nuclear location signal and its effect on virus replication in HepG2.2.15 Cells[J]. Journal of Clinical Hepatology, 2010, 26(4): 387-391.
[18]	Chen Sheng, Lin ChaoShuang. The relationship between liver function and immune system and viral replication in patients with viral hepatitis[J]. Journal of Clinical Hepatology, 2007, 23(2): 94-95.
[19]	Yang XiaoJuan, Wu GuoRong, Lu ZhongHua, Pei Hao, Qian JinJuan. Clinical signification of detecting PreS;antigen for identifying viral replication in patients with HB without HbeAg[J]. Journal of Clinical Hepatology, 2007, 23(5): 340-341.

Supplements(0)

Cited By

Cited by

Periodical cited type(6)

1.	张明. 酒精性肝病合并乙型肝炎病毒感染病例临床分析. 中国医药指南. 2024(02): 114-116 .
2.	吴琦玮，高杨，李艳辉，沈榕. 2015—2019年北京地区乙型肝炎疾病负担及趋势预测分析. 实用预防医学. 2024(11): 1349-1352 .
3.	董丹丹，邱利，胡毅. 慢性HBV感染合并非酒精性脂肪性肝病患者血清脂联素、ROS及糖脂代谢特征. 肝脏. 2024(10): 1265-1268+1273 .
4.	毛垚耀，何惠昌，谢露，崔健娇，刘光伟. 健脾活血解毒方联合恩替卡韦对乙型病毒性肝炎合并非酒精性脂肪性肝病小鼠的干预作用及机制. 现代中西医结合杂志. 2023(08): 1047-1052 .
5.	沈从乐，李韦杰，任博，孙继云，王雅杰. 2543例不同病因慢性肝病糖脂代谢异常率分析. 标记免疫分析与临床. 2022(09): 1451-1454 .
6.	倪盟，曾雷. miRNA单核苷酸多态性与HBV感染相关疾病关系的研究进展. 吉林大学学报(医学版). 2021(06): 1588-1593 .

Other cited types(1)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (1405) PDF downloads(258)

Clinical and prognostic features of acute alcoholic pancreatitis

DOI: 10.3969/j.issn.1001-5256.2019.11.027